NIOX Group PLC
Research NIOX Group PLC (NIOX) on Bullrun: market cap GBX 28.87B, P/E 34.3, dividend yield 2.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNIOX
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryMedical Devices
- CurrencyGBX
- Market capGBX 28.87B
- P/E34.3
- Dividend yield2.3%
- Financial periodFY2025
- RevenueGBP 48.70M
- Revenue growth16.5%
- Net incomeGBP 7.00M
- Free cash flowGBP 13.90M
- Gross margin69.2%
Valuation Snapshot
latest market cap is GBX 28.87B; P/E is 34.3; dividend yield is 2.3%.
Peer valuation comparison
Latest P/E is 34.3x versus a Healthcare sector median of 24.46x (40.2% above).
Latest dividend yield is 2.28% versus a Healthcare sector median of 2.11% (8.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 48.70M | GBP 7.00M | GBP 13.90M | 69.2% | 0.02 | GBP 19.90M | GBP 1.00M | GBP 67.60M |
| FY2024 | GBP 41.80M | GBP 3.70M | GBP 16.20M | 72.2% | 0.01 | GBP 10.90M | GBP 1.50M | GBP 59.50M |
| FY2023 | GBP 36.80M | GBP 10.70M | GBP 11.30M | 72.0% | 0.02 | GBP 19.90M | GBP 1.10M | GBP 83.80M |
| FY2022 | GBP 31.30M | GBP 16.10M | GBP 6.60M | 70.9% | 0.04 | GBP 19.40M | GBP 1.00M | GBP 81.90M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | GBX 28.87B | 34.3 | 2.3% | 0.02 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.02 GBX, yield 2.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.25 GBP |
| FY2024 | 1 GBP |
| FY2023 | 2.5 GBP |
About NIOX Group PLC
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NIOX Group PLC's market cap?
NIOX Group PLC's market capitalization is GBX 28.87B.
What is NIOX Group PLC's P/E ratio?
NIOX Group PLC's price-to-earnings (P/E) ratio is 34.3.
Does NIOX Group PLC pay a dividend?
NIOX Group PLC has a dividend yield of 2.3%.
What does NIOX Group PLC do?
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022.